371 related articles for article (PubMed ID: 31695608)
1. Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes.
Oyer HM; Sanders CM; Kim FJ
Front Pharmacol; 2019; 10():1141. PubMed ID: 31695608
[TBL] [Abstract][Full Text] [Related]
2. Sigma1 Pharmacology in the Context of Cancer.
Kim FJ; Maher CM
Handb Exp Pharmacol; 2017; 244():237-308. PubMed ID: 28744586
[TBL] [Abstract][Full Text] [Related]
3. Introduction to Sigma Proteins: Evolution of the Concept of Sigma Receptors.
Kim FJ
Handb Exp Pharmacol; 2017; 244():1-11. PubMed ID: 28871306
[TBL] [Abstract][Full Text] [Related]
4. Study of the Relationship between Sigma Receptor Expression Levels and Some Common Sigma Ligand Activity in Cancer Using Human Cancer Cell Lines of the NCI-60 Cell Line Panel.
Sereti E; Tsimplouli C; Kalaitsidou E; Sakellaridis N; Dimas K
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33466391
[TBL] [Abstract][Full Text] [Related]
5. The Molecular Function of σ Receptors: Past, Present, and Future.
Schmidt HR; Kruse AC
Trends Pharmacol Sci; 2019 Sep; 40(9):636-654. PubMed ID: 31387763
[TBL] [Abstract][Full Text] [Related]
6. The Sigma Receptors in Alzheimer's Disease: New Potential Targets for Diagnosis and Therapy.
Wang T; Jia H
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569401
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σ
Xie XY; Li YY; Ma WH; Chen AF; Sun YT; Lee JY; Riad A; Xu DH; Mach RH; Huang YS
Eur J Med Chem; 2021 Jan; 209():112906. PubMed ID: 33049607
[TBL] [Abstract][Full Text] [Related]
8. Selectivity profile comparison for certain γ-butyrolactone and oxazolidinone-based ligands on a sigma 2 receptor over sigma 1: a molecular docking approach.
Bhandare RR; Sigalapalli DK; Shaik AB; Canney DJ; Blass BE
RSC Adv; 2022 Jul; 12(31):20096-20109. PubMed ID: 35919619
[TBL] [Abstract][Full Text] [Related]
9. TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death.
Zeng C; Weng CC; Schneider ME; Puentes L; Riad A; Xu K; Makvandi M; Jin L; Hawkins WG; Mach RH
Cell Death Discov; 2019; 5():58. PubMed ID: 30701090
[TBL] [Abstract][Full Text] [Related]
10. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes.
Bouchard P; Quirion R
Neuroscience; 1997 Jan; 76(2):467-77. PubMed ID: 9015331
[TBL] [Abstract][Full Text] [Related]
11. Highly specific σ
Yousuf MS; Sahn JJ; Yang H; David ET; Shiers S; Moreno MM; Iketem J; Royer DM; Garcia CD; Zhang J; Hong VM; Mian SM; Ahmad A; Kolber BJ; Liebl DJ; Martin SF; Price TJ
bioRxiv; 2023 Oct; ():. PubMed ID: 37090527
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.
Romeo G; Prezzavento O; Intagliata S; Pittalà V; Modica MN; Marrazzo A; Turnaturi R; Parenti C; Chiechio S; Arena E; Campisi A; Sposito G; Salerno L
Eur J Med Chem; 2019 Jul; 174():226-235. PubMed ID: 31042618
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.
Colabufo NA; Berardi F; Contino M; Niso M; Abate C; Perrone R; Tortorella V
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):106-13. PubMed ID: 15322732
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma2 ligands.
Couture S; Debonnel G
Synapse; 1998 May; 29(1):62-71. PubMed ID: 9552175
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
